PathoQuest is pleased to announce that it has received Propel Certification from Illumina after successfully completing the requirements for achieving this recognition. This included demonstrating the ability to produce high-quality data on the NexSeq System following a streamlined and rigorous process. PathoQuest’s Propel Certification is valid for the company’s Biologics Genomic Service projects which utilize Illumina’s NGS library preparation and sequencing protocols.

.

.Propel Certification enables our customers to feel confident that they are receiving the highest quality data, insight, and service when PathoQuest utilizes Illumina’s technology for projects.